Merck Message Board - Msg: 3490790

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck

MRK 94.96

-0.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EepOpp who wrote (524)	2/20/1998 8:31:00 PM
From: Brian Malloy	Read Replies (2) of 1580

Unfortunately, many of the analysts that comment on MRK have MBA's not backgrounds in Pharmacology. The MRK pipeline is not going to dry up and MRK disappear from the face of the earth in five years. Many of these same analysts were prognosticating in 1993/1994 during Mrs. Clinton's Universal Healthplan proposal that MRK and all the drug companies were going to be squeezed out of business. Instead MRK has gone from $28 or so at its low back then to its current level. Crixivan, Propecia, less than a year old, being sold now. This year will in all likelihood bring an updated HBV vaccine, improved B2 agonist for asthma, HIV vaccine, and a COX2 inhibitor to name a few. Throughout its history, MRK has always had drugs going off patent and new ones comming on patent. In my opinion, the reason MRK is really moving now is that the analysts are seeing that all their talk about MRK not having new products (which they stated spewing forth about two years ago) is wrong. Of course they probably will not come out and say that.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next